A controlled trial of photodynamic therapy of actinic keratosis comparing different red light sources

被引:10
|
作者
Giehl, Kathrin A. [1 ]
Kriz, Martin [1 ,2 ]
Grahovac, Maja [1 ]
Ruzicka, Thomas [1 ]
Berking, Carola [1 ]
机构
[1] Univ Munich, Dept Dermatol & Allergol, D-80337 Munich, Germany
[2] Klinikum Augsburg, Dept Dermatol & Allergol, D-86156 Augsburg, Germany
关键词
actinic keratosis; ALA; broad-spectrum; photodynamic therapy; controlled trial; red light; NONMELANOMA SKIN-CANCER; BASAL-CELL CARCINOMA; INTERNATIONAL CONSENSUS; EMITTING-DIODES; DOUBLE-BLIND; BF-200; ALA; PHASE-III; IN-VITRO; PAIN; PLACEBO;
D O I
10.1684/ejd.2014.2364
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Photodynamic therapy (PDT) using 5-aminolevulinic acid (ALA) with red light is well established for actinic keratosis (AK). Differences have been observed concerning pain and efficacy rates with different red light sources. Objectives: To compare pain scores, short- and long-term efficacy rates of PDT of multiple AKs when employing different red light sources.. Material and methods: In a controlled trial, 88 patients (310 AK lesions) received ALA-PDT in combination with either visible light (VIS) + water-filtered infrared A (wIRA) light (PhotoDyn (R) 750 (PD750), 580-1400 nm) for 30 min or incoherent light (Waldmann (R) 1200L (Wa1200L), 600-720 nm) for 10-11 min. Followup visits were performed after 1, 3, 6, and 12 months. if there was no complete cure after 1, 3 or 6 months, a second cycle of PDT was performed. Results: Pain scores were significantly lower in patients illuminated with PD750 rather than Wa1200L. Patient complete clearance rates were 85% and 91% after 1 month, 79% and 92% after 3 months, 97% and 92% after 6 months, and 69% and 85% after 12 months in the PD750 and Wa1200L groups, respectively. Lesion complete clearance rates were 94% and 92% after 1 month, 88% and 97% after 3 months, 96% and 95% after 6 months, and 81% and 89% after 12 months in the PD750 and Wa1200L group, respectively. The efficacy rates were not significantly different. Conclusion: A VIS + wIRA light source produced considerably less pain, while efficacy was not much affected in contrast to previously published studies, probably because the illumination time was longer in this study.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 50 条
  • [31] High efficacy of red light photodynamic therapy with 10 % aminolevulinic acid gel irrespective of the extent of keratinocyte atypia in actinic keratosis - exploratory post-hoc analysis of three pivotal phase III trials
    Bierhoff, E.
    Szeimies, R. -M.
    Reinhold, U.
    Dirschka, T.
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2024, 50
  • [32] Photodynamic Therapy with 5-Aminolevulinic Acid Patch for the Treatment of Actinic Keratosis
    Kiss, Norbert
    Farkas, Klara
    Tosti, Giulio
    De Gado, Federico
    Bergler-Czop, Beata
    Fazia, Gilda
    Tammaro, Antonella
    Cantisani, Carmen
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)
  • [33] Photodynamic therapy in the management of actinic keratosis: Retrospective evaluation of outcome
    Jerjes, Waseem
    Hamdoon, Zaid
    Abdulkareem, Ali A.
    Hopper, Colin
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2017, 17 : 200 - 204
  • [34] Actinic keratosis area and severity index is not correlated with photodynamic therapy procedural pain
    Sharma, Amit
    Vincent, Laura
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2020, 31
  • [35] Potency of different red light sources in photodynamic induction of cell death in a squamous cell carcinoma cell line
    Novak, Ben
    Peteja, Monika
    Brueck, Thomas
    Luebbert, Hermann
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2016, 14 : 128 - 130
  • [36] Comparison of three light doses in the photodynamic treatment of actinic keratosis using mathematical modeling
    Vignion-Dewalle, Anne-Sophie
    Betrouni, Nacim
    Tylcz, Jean-Baptiste
    Vermandel, Maximilien
    Mortier, Laurent
    Mordon, Serge
    JOURNAL OF BIOMEDICAL OPTICS, 2015, 20 (05)
  • [37] Comparative study of imiquimod 3.75% vs. photodynamic therapy for actinic keratosis of the scalp
    Cortelazzi, Chiara
    Odorici, Giulia
    Castagnetti, Elisa
    Pellacani, Giovanni
    Di Nuzzo, Sergio
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2021, 37 (05) : 404 - 409
  • [38] Studies of Methyl Aminolevulinate Photodynamic Therapy for Actinic Keratosis
    Fernandez-Guarino, M.
    Harto, A.
    Jaen, P.
    ACTAS DERMO-SIFILIOGRAFICAS, 2010, 101 (04): : 315 - 322
  • [39] Advances in Photodynamic Therapy for the Treatment of Actinic Keratosis and Nonmelanoma Skin Cancer: A Narrative Review
    Aaron S. Farberg
    Justin W. Marson
    Teo Soleymani
    Dermatology and Therapy, 2023, 13 : 689 - 716
  • [40] Application of photodynamic therapy with the use of superluminescent light-emitting diode (sLED) lamp in actinic keratosis
    Bartosinska, Joanna
    Gerkowicz, Agnieszka
    Niewiedziol, Marta
    Szczepanik-Kulak, Paulina
    Kwasny, Mirostaw
    Krasowska, Dorota
    PRZEGLAD DERMATOLOGICZNY, 2019, 106 (04): : 372 - 383